Transforming healthcare through intelligent cardiovascular monitoring

We empower health systems to deliver stronger financial performance, reduce pressure on clinical resources, whilst driving better patient outcomes

Measuring, analysing and diagnosing the electrical and mechanical activity of the heart and vascular system in a simple, fast, 30-second, out-of-hospital test. Delivering clinical teams' immediate intelligent advice and diagnostic support.

Current capability includes Cardiac Rhythm Analysis, detection of Heart Failure and undiagnosed AF, Stroke Prevention and Rehab support

The Healthcare Challenges

Healthcare systems face mounting pressures from ageing populations, limited resources, and rising costs — demanding transformative solutions.
Overwhelmed Systems
66 million+ people in US and UK with Heart Disease/COPD. An ageing population with chronic conditions continues to strain healthcare infrastructure, creating bottlenecks that compromise care quality and accessibility.
Unsustainable Costs
In the US, $254 billion+ in admissions and $56 billion+ in readmissions, with reimbursement rates below costs. In the UK, lengthy waiting lists result from emergency admissions and extended length of stay.
Resource Shortages
Critical nursing shortages exceed 12% vacancy rates. US rural hospital closures reached 18 in 2024, with 46% operating at a loss. Limited specialist access affects 80% of US counties without a cardiologist.
Escalating Burden
Chronic patients drive frequent service use, have complex care needs, and experience avoidable emergencies and readmissions. This results in reduced life expectancy and diminished quality of life across patient populations.
Remote Patient Monitoring (RPM)
Whilst RPM delivers results, high nurse triage costs arise due to first-generation system limitations. Blood pressure measurements and related metrics cause alert overload, diminishing system effectiveness.

ARTEMIS™ Platform

ARTEMIS™ features specialised handheld devices available in clinic or at home, capable of measuring and recording the electrical and mechanical activity of a patient's heart and vascular system in just 30 seconds. Results are transmitted to the secure cloud service,, where AI-powered analysis delivers comprehensive findings and potential diagnoses to clinicians.



Our technology identifies underlying cardiovascular, vascular, and respiratory conditions whilst providing early detection of deterioration, enabling immediate appropriate preventative care for better patient outcomes.

Cardiovue™

An AI-enabled analytical and diagnostic SaMD cloud suite delivering timely analysis, findings, and diagnosis of cardiac, respiratory, and vascular problems.

CarePortal™

CARDIOX™ embedded into a fit-for-purpose handheld Android tablet which replaces patients' tablet/phone. Runs the RPM vendor's app or our Point of Care (POC) app, ensuring digital equality and easy access for all patient demographics.

HealthHub™

CARDIOX™ embedded into a handheld Bluetooth-enabled device that connects to an RPM vendor's app running on a tablet/phone, offering a lower-cost option whilst maintaining diagnostic capability.

Cardiox™

Embedded into CAREPORTAL™ and HEALTHHUB™, an advanced electronic cardiovascular sensor, refined over 15 years, that uses the body as the sensor.

What are our Key Differentiators

ARTEMIS™ goes beyond traditional monitoring with advanced cardiovascular diagnostics, enhancing RPM and Primary Care systems to deliver greater clinical value, stronger ROI, and unlock new revenue opportunities.

CARDIOX™
Body-as-Sensor Technology

Unique and rapid out-of-hospital cardiovascular data collection using proprietary sensing methodology, representing a paradigm shift in cardiac assessment capabilities.

CARDIOVUE™
AI-Driven Analytics

Novel comprehensive remote cardiovascular care insights through advanced machine learning algorithms, delivering precise diagnostic capabilities previously unavailable outside hospital settings.

CAREPORTAL®
Handheld Device

Unique devices supporting patients with wide-ranging cognitive and technical abilities, enhanced from proven technology used by over 15,000 cardiac and COPD patients.

CARDIOX™ Body-as-Sensor Technology
Unique and rapid out-of-hospital cardiovascular data collection using proprietary sensing methodology, representing a paradigm shift in cardiac assessment capabilities.
CARDIOVUE™ AI-Driven Analytics
Novel comprehensive remote cardiovascular care insights through advanced machine learning algorithms, delivering precise diagnostic capabilities previously unavailable outside hospital settings.
CAREPORTAL® Handheld Device
Unique devices supporting patients with wide-ranging cognitive and technical abilities, enhanced from proven technology used by over 15,000 cardiac and COPD patients.
Current blood pressure measurement is analogous to touching a radiator to assess the health of an entire heating system. ARTEMIS™ measures the actual state of the "pump and pipes" for comprehensive cardiac evaluation.

The Triple P Value Proposition

PAYER BENEFITS

Decreased Healthcare Costs
  • Over 50% fewer admissions through early detection
  • Reduced expensive in-hospital diagnostic testing
  • Resource optimisation delivering £3 saved for every £1 spent
  • Improved medication management reduces overall costs

PROVIDER BENEFITS

Increased Revenue & Efficiency
  • Higher acuity occupancy rates maximising bed utilisation
  • Over 50% reduction in readmissions and 70% reduction in length of stay
  • Improved case mix generating enhanced revenue streams
  • Improved workforce satisfaction through efficient workflows

PATIENT BENEFITS

Enhanced Healthcare Quality
  • Early detection of cardiac and respiratory conditions
  • Personalised, data-driven care tailored to individual needs
  • Faster diagnostic decisions reducing anxiety and uncertainty
  • Convenient home monitoring avoiding hospital visits

Markets we address

Remote Patient Monitoring Market

Embedded in Remote Patient Monitoring (RPM) platforms for large scale health systems monitoring of at-risk cardiac and respiratory patients in the community
‍
Potential users include: Health systems, Hospitals, Managed Care Providers, Community providers for large scale health systems monitoring at-risk cardiac and respiratory patients in the community

Target population requiring monitoring

70 million

Addressable Market
(10% require ARTEMIS capability)

7 million

Route to market to Healthcare Providers:

RPM Vendors

Point of Care Assessment Market

Point of Care (POC) solution for Primary Care physician as an alternative to hospital-based tests, and supports rural patient access to advanced diagnostics at local physician’s office

Potential users include: Cardiology clinics, Outpatient care providers and General Practice Care physicians, an alternative to hospital-based tests and support for rural patient access to advanced diagnostics at local physician’s office.

GP Physicians in US
(Primary Care market opportunity)

160k+

GP Practices in UK
(Drive for more POC at Primary Care level)

7,200+

Route to market for POC offering:

Medical Device Distributors

Contact us

Fill out the from or email us at
enquiries@docomed.ai

By submitting you understand Docomed’s data privacy policy
Thank you! Your message has been sent!
Oops! There was an error with your submission.